Serum β2-microglobulin in patients with non-Hodgkin's lymphoma
- 1 March 1983
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 19 (3) , 327-331
- https://doi.org/10.1016/0277-5379(83)90129-3
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Serum beta-2-microglobulin in multiple myeloma: Relation to presenting features and clinical statusEuropean Journal of Cancer and Clinical Oncology, 1982
- Beta 2-microglobulin in haematological malignancies.BMJ, 1981
- Intensive combination chemotherapy with vincristine, adriamycin and prednisolone (VAP) in the treatment of diffuse histology non-hodgkin's lymphomaPublished by Elsevier ,1980
- Serum beta 2 microglobulin and C-reactive protein in the monitoring of lymphomas findings in a multicenter study and experience in selected patientsCancer, 1980
- Chemotherapy of advanced non-Hodgkin's lymphomaClinics in Haematology, 1979
- Serum β2 microglobulin and its prognostic value in lymphomasPublished by Elsevier ,1979
- β2-MICROGLOBULIN, A TUMOUR MARKER OF LYMPHOPROLIFERATIVE DISORDERSThe Lancet, 1978
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Isolation and Properties of a Low Molecular Weight β2-Globulin Occurring in Human Biological FluidsPublished by Elsevier ,1968